Skip to main content
. 2011 Jan;162(1):111–125. doi: 10.1111/j.1476-5381.2010.01032.x

Figure 7.

Figure 7

Effects of peroxisome proliferator-activated receptor (PPAR) agonists on the expression of Bcl-2 or Bax. Cells were treated with gemfibrozil (10 µM), GW0742 (0.1 µM), pioglitazone (1 µM) or rosiglitazone (0.1 µM) following Protocol 3 and exposed to serum deprivation (SD; 48 h). (A) Bcl-2 and Bax expression was determined by Western blot analysis. Results are expressed as mean ± SEmean of four experiments run in triplicate. **P < 0.01 versus vehicle alone; °P < 0.01 versus basal.